Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07624370Enrolling By Invitation

Frailty in the Elderly Oncological and Oncohematological Patient.

Role: lead

NCT07628205Phase 2Enrolling By Invitation

Preoperative Botulinum Toxin A to Facilitate Midline Closure in Large Chronic Ventral Hernias

Role: lead

NCT07518524Not ApplicableRecruiting

Ultra Fast-Track vs Fast-Track Protocols in Off-Pump and Minimally Invasive Valve Cardiac Surgery

Role: lead

NCT07496112Enrolling By Invitation

Clinical Outcomes of Bioactive Glass S53P4 in Radical Mastoid Cavity Obliteration

Role: lead

NCT07433114Not ApplicableCompleted

Erector Spinae Plane Block (ESP) vs Serratus Anterior Plane Block (SAP) for Loco-Regional Analgesia in Adult Patients Undergoing Minimally Invasive Cardiac Surgery Via Mini-Thoracotomy: Impact on Morphine Consumption, Pain Control, and Quality of Recovery

Role: lead

All 5 trials loaded